Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;30(28):2500452.
doi: 10.2807/1560-7917.ES.2025.30.28.2500452.

Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024

Affiliations

Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024

Louise Roer et al. Euro Surveill. 2025 Jul.

Abstract

We describe the genetic characteristics of a fusidic acid- and meticillin-resistant Staphylococcus aureus (MRSA) clone widespread in Europe, based on whole genome sequences from 317 isolates. The clone is causing impetigo and other skin and soft tissue infections, primarily in young children. Comparison with publicly available S. aureus ST121 sequences showed that the clone is clearly distinct from previously described ST121 clones. European and other international readers should be aware of the emergence of this community-acquired MRSA clone.

Keywords: Methicillin-resistance; Staphylococcus aureus; fusidic acid resistance; impetigo; international clone; multi-resistance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Phylogenetic tree of seven genes, colour-coded by country.
Figure 1
Single nucleotide polymorphism phylogeny of Staphylococcus aureus ST121, sequences from European reference laboratories and the NBCI database, 1932–2024 (n = 1,188)
Column graph showing case numbers by age group, colour-coded for samples from infections vs screening; the larger part of samples were from infections
Figure 2
Age distribution of cases with FAR-MRSA, divided into infections and non-infections (screening samples), 11 European countries, 2014–2024 (n = 315)
Column graph showing case numbers by country, with the highest numbers in the Netherlands, Denmark and then France
Figure 3
Number of isolates belonging to the FAR-MRSA clone, by country of isolation, 11 European countries, 2014–2024 (n = 317)
Columns graph showing case numbers rising from July and falling after October
Figure 4
Number of isolates per month for all cases with available date of isolation, irrespective of year and country, 11 European countries, 2014–2024 (n = 314)

References

    1. O’Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol. 2007;45(5):1505-10. 10.1128/JCM.01984-06 - DOI - PMC - PubMed
    1. Vendrik KEW, Kuijper EJ, Dimmendaal M, Silvis W, Denie-Verhaegh E, de Boer A, et al. An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant Staphylococcus aureus with additional resistance to fusidic acid, June 2018 to January 2020. Euro Surveill. 2022;27(49):2200245. 10.2807/1560-7917.ES.2022.27.49.2200245 - DOI - PMC - PubMed
    1. Yin N, Michel C, Makki N, Deplano A, Milis A, Prevost B, et al. Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of Staphylococcus aureus, Belgium, 2013 to 2023. Euro Surveill. 2024;29(19):2300668. 10.2807/1560-7917.ES.2024.29.19.2300668 - DOI - PMC - PubMed
    1. O’Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother. 2007;51(5):1737-40. 10.1128/AAC.01542-06 - DOI - PMC - PubMed
    1. Deplano A, Hallin M, Bustos Sierra N, Michel C, Prevost B, Martiny D, et al. Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium. J Antimicrob Chemother. 2023;78(8):2061-5. 10.1093/jac/dkad204 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources